November 11, 2019 Here's why there are no new treatments for lupus At the American College of Rheumatology annual meeting underway in Atlanta today, Dr. Konstantinos Tselios of the University of Toronto addresses the challenges associated with developing new treatments for systemic lupus. Read more   ADVERTISEMENT Abatacept Monotherapy Effective in JIA Monotherapy with intravenous (IV) or subcutaneous (SC) abatacept was safe and effective in patients with polyarticular-course juvenile idiopathic arthritis (pJIA) who couldn’t tolerate or didn’t respond to methotrexate, researchers reported November 11 at the annual meeting of the American College of Rheumatology in Atlanta. Read more